ME/CFS Research Summaries

Tag: ⭐-Landmark✕

44 items with this tag.

Dec 22, 2025
Machine Learning Analysis of Post-Acute COVID Symptoms Identifies Distinct Clusters, Severity Groups, and Trajectories
- 🧪-Biomarker
- ⭐-Landmark
Dec 16, 2025
Mapping the complexity of ME/CFS: Evidence for abnormal energy metabolism, altered immune profile, and vascular dysfunction.
- 🧪-Biomarker
- ⭐-Landmark
Dec 12, 2025
Long COVID involves activation of proinflammatory and immune exhaustion pathways
- ⭐-Landmark
- 🧪-Biomarker
Dec 10, 2025
Large-scale investigation confirms TRPM3 ion channel dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- 🧪-Biomarker
- ⭐-Landmark
Dec 08, 2025
Comparable Immune Alterations and Inflammatory Signatures in ME/CFS and Long COVID
- 🧪-Biomarker
- ⭐-Landmark
Dec 05, 2025
Persistent Attenuation of Lymphocyte Subsets After Mass SARS-CoV-2 Infection
- 🧪-Biomarker
- ⭐-Landmark
Dec 04, 2025
The lingering shadow of epidemics: post-acute sequelae across history.
- 🧪-Biomarker
- ⭐-Landmark
Dec 03, 2025
Identification of Novel Reproducible Combinatorial Genetic Risk Factors for Myalgic Encephalomyelitis in the DecodeME Patient Cohort and Commonalities with Long COVID
- 🧪-Biomarker
- ⭐-Landmark
Dec 02, 2025
Risk Factors for Severe Post-COVID Condition in Children, Adolescents, and Young Adults
- 🧪-Biomarker
- ⭐-Landmark
Dec 01, 2025
Microstructural White Matter Impairments in Chronic Fatigue Syndrome: Evidence of Segmental Injury in the Cingulum Bundle
Nov 28, 2025
Exploring a genetic basis for the metabolic perturbations in ME/CFS using UK Biobank
- 🧪-Biomarker
- ⭐-Landmark
Nov 26, 2025
SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis
- ⭐-Landmark
- 🧪-Biomarker
Nov 18, 2025
Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME/CFS
- 🧪-Biomarker
- ⭐-Landmark
Nov 15, 2025
Temporal dynamics of the plasma proteomic landscape reveals maladaptation in ME/CFS following exertion
- 🧪-Biomarker
- ⭐-Landmark
Oct 24, 2025
HLA and pathogens in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and other post-infection conditions
- 🧪-Biomarker
- ⭐-Landmark
Oct 21, 2025
Low-dose rapamycin alleviates clinical symptoms of fatigue and PEM in ME/CFS patients via improvement of autophagy: a pilot study
Oct 08, 2025
Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profiling
- 🧪-Biomarker
- ⭐-Landmark
Oct 01, 2025
Systemic increase of AMPA receptors associated with cognitive impairment of long COVID
- 🧪-Biomarker
- ⭐-Landmark
Sep 03, 2025
Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in ME/CFS
- 🧪-Biomarker
- ⭐-Landmark
Aug 30, 2025
Global Prevalence of Long COVID, Its Subtypes, and Risk Factors: An Updated Systematic Review and Meta-analysis
- ⭐-Landmark
Aug 28, 2025
Haptoglobin phenotypes and structural variants associate with post-exertional malaise and cognitive dysfunction in myalgic encephalomyelitis
- 🧪-Biomarker
- ⭐-Landmark
Aug 26, 2025
Mapping cerebral blood flow in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and orthostatic intolerance: insights from a systematic review
- 🧪-Biomarker
- ⭐-Landmark
Aug 24, 2025
Praxisleitfaden Myalgische Enzephalomyelitis / Chronisches Fatigue Syndrom (ME/CFS)
- ⭐-Landmark
- 💊-Treatment
Aug 19, 2025
Causes of symptoms and symptom persistence in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome
- ⭐-Landmark
Aug 11, 2025
Circulating cell-free RNA signatures for the characterization and diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome
- 🧪-Biomarker
- ⭐-Landmark
Aug 11, 2025
Microfluidic assessment of PO2-regulated RBC capillary velocity in ME/CFS
Aug 10, 2025
ME/CFS and PASC Patient-Derived Immunoglobulin Complexes Disrupt Mitochondrial Function and Alter Inflammatory Marker Secretion
- 🧪-Biomarker
- ⭐-Landmark
Aug 07, 2025
A Perspective on the Role of Metformin in Treating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID
Aug 06, 2025
Initial findings from the DecodeME genome-wide association study of myalgic encephalomyelitis/chronic fatigue syndrome
- 🧪-Biomarker
- ⭐-Landmark
Jul 25, 2025
AI-driven multi-omics modeling of myalgic encephalomyelitis/chronic fatigue syndrome
- 🧪-Biomarker
- ⭐-Landmark
Jul 09, 2025
Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome-a clinical pilot study
Jul 08, 2025
Patient-reported treatment outcomes in ME/CFS and long COVID
- ⭐-Landmark
- 💊-Treatment
Jul 07, 2025
SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis
May 19, 2025
Low-Dose naltrexone restored TRPM3 ion channel function in natural killer cells from long COVID patients
May 16, 2025
The sensitising effect of IgG in fibromyalgia syndrome is mediated by Mrgprb2 in mast cells
- ⭐-Landmark
- 🧪-Biomarker
Apr 01, 2025
Microvascular Dysfunction and Basal Membrane Thickening in Skeletal Muscle in ME/CFS and Post-COVID
- 🧪-Biomarker
- ⭐-Landmark
Feb 21, 2025
Off-Label Drug List for ME/CFS and Post-Acute Infection Syndromes
Nov 06, 2024
Key Pathophysiological Role of Skeletal Muscle Disturbance in Post COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Accumulated Evidence
Apr 08, 2024
Longitudinal cytokine and multi-modal health data of an extremely severe ME/CFS patient with HSD reveals insights into immunopathology, and disease severity
Feb 21, 2024
Chronic fatigue syndrome linked to widespread energy, immune and vascular changes
- 🧪-Biomarker
- ⭐-Landmark
Jan 06, 2024
Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives
Jun 08, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
- ⭐-Landmark
- 💊-Treatment
May 15, 2022
Acute Effect of Pyridostigmine in Exertional Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Randomized Placebo-Controlled Clinical Trial
Feb 10, 2015
Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness
- 🧪-Biomarker
- ⭐-Landmark

Created with Quartz v4.5.2 © 2025

Home
GitHub
Imprint